Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

What sticks out to me is the actual earnings per share versus the trumped up non GAAP number. That is very likely at least part of the street's negative reaction.

The attempt by the new CFO to distract from that disappointing number was just too obvious and smelled to high heaven. Who did she think she was talking to? A bunch of penny stock gamblers?

She certainly has Helen's ear nowadays, though, and that is concerning to me. This stock has taken a beating since the old CFO left suddenly and that new woman emerged with her "financial engineering" shell games - and we were at all time highs with the wind at our backs until then.

I continue to worry also about what they are cooking up with that $800 million. I'm pretty sure we'll take another hit if they buy some company in a deal that does not look like an outright steal, and of course that's probably not happening.

And speaking of dilution, did you get a chance to see the new compensation package passed in the last annual meeting? What do you think of that?